Please see below all current neuro-oncology clinical trials of the Central Coast Cancer Centre.
A Randomized Phase II Open Label Study of Nivolumab and temozolomide vs Temozolomide in Newly Diagnosed Older Subjects with Methylated MGMT (tumor O-6-methylguanine DNA methyltransferase) Glioblastoma.
Principal Investigator: Dr Matthew Wong
Study Coordinator: Richard Clayton
More information about VERTU
For more information about medical oncology clinical trials please contact the Nurse Unit Manager on 02 4320 9890 or see: